Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAccepted Article

Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis

Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay and Iván Ferraz-Amaro
The Journal of Rheumatology November 2019, jrheum.190729; DOI: https://doi.org/10.3899/jrheum.190729
Natalia Palmou-Fontana
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Martínez-Lopez
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfonso Corrales
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Rueda-Gotor
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernanda Genre
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susana Armesto
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcos A. González-López
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Quevedo-Abeledo
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Portilla-González
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Blanco
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José L. Hernandez
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Llorca
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Á. González-Gay
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iván Ferraz-Amaro
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro{at}hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay{at}hotmail.com.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
Next
Loading

Abstract

Objective Since the addition of carotid ultrasound into composite cardiovascular risk (CVR) scores has been found effective for identifying patients with inflammatory arthritis and high CVR, we aimed to determine if its use would facilitate the reclassification of patients with psoriatic arthritis (PsA) into the very-high-risk SCORE (Systematic Coronary Risk Evaluation) category and whether this might be related to disease features.

Methods Cross-sectional study involving 206 patients who fulfilled CASPAR criteria for PsA and 197 controls. We assessed lipid profile, SCORE, disease activity measurements, and the presence of carotid plaques and carotid intima-media thickness by ultrasonography. A multivariable regression analysis, adjusted for classic CVR factors, was performed to evaluate if the risk of reclassification could be explained by disease-related features and to assess the most parsimonious combination of risk reclassification predictors.

Results Forty-seven percent of patients were reclassified into a very-high SCORE risk category after carotid ultrasound compared to 26% of controls (p=0.000). Patients included in the low-risk SCORE category were those who were more commonly reclassified (30% vs. 14%, p=0.002). The DAPSA score was associated with reclassification (beta coefficient 1.10 [95%CI 1.02-1.19], p=0.019) after adjusting for age and traditional CVR factors. A model containing SCORE plus age, statin use, and DAPSA score yielded the highest discriminatory accuracy compared to the SCORE alone model (AUC 0.863 [95%CI 0.789-0.936] vs. 0.716 [95%CI 0.668-0.764], p=0.000).

Conclusion PsA patients are more frequently reclassified into the very-high SCORE risk category following carotid ultrasound assessment than controls. This was independently explained by the disease activity.

Next
Back to top

In this issue

The Journal of Rheumatology: 53 (9)
The Journal of Rheumatology
Vol. 53, Issue 9
1 Sep 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted manuscript
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Nov 2019, jrheum.190729; DOI: 10.3899/jrheum.190729

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Accepted manuscript
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Nov 2019, jrheum.190729; DOI: 10.3899/jrheum.190729
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire